Artisan Small Cap remains mired in a multiyear performance rut, but a thoughtful investment process and experienced leadership are reasons to remain optimistic. The team is sticking to its core investment philosophy, but the managers made changes to the analyst team, showing that they're not just hoping things will turn around.
Artisan Small Cap Fund Investor Shares ARTSX
- NAV / 1-Day Return 39.32 / +0.61 %
- Total Assets 890.5M
-
Adj. Expense Ratio
1.250%
- Expense Ratio 1.250%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 65%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:11 AM GMT+0
Morningstar’s Analysis ARTSX
Will ARTSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 38.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Twist Bioscience Corp | 5.56 | 53M | Healthcare |
Modine Manufacturing Co | 4.97 | 48M | Consumer Cyclical |
Lattice Semiconductor Corp | 4.43 | 42M | Technology |
Compass Inc Class A | 3.95 | 38M | Real Estate |
Cognex Corp | 3.65 | 35M | Technology |
VSE Corp | 3.43 | 33M | Industrials |
Ascendis Pharma AS | 3.26 | 31M | Healthcare |
SPX Technologies Inc | 3.13 | 30M | Industrials |
Marex Group Ltd | 3.01 | 29M | Financial Services |
Ionis Pharmaceuticals Inc | 2.96 | 28M | Healthcare |
United States